MUSTANG BIO, INC. (MBIO)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

0.40 on 9 Oct 2026

1 buy2 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$1.92M

Free cash flow

$5.26M

Return on equity

-20.2%

Return on capital

-20.2%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
30 Dec 2025	Herskowitz Neil Director	Sold at will	$237.61	63.0%
30 Dec 2025	Jin David Director	Bought	$237.61	633%
30 Dec 2025	Chill Adam J. Director	Sold at will	$3.82	1.1%
13 Sep 2022	Litchman Manuel MD Director	Bought	$2.58K	0.5%
13 Sep 2022	ROSENWALD LINDSAY A MD Director	Bought	$2.58K	1.7%
18 Mar 2022	Litchman Manuel MD Director	Bought	$3.70K	0.5%

31out of 100

Profitability 0

Financial strength 48

Growth n/a

Insiders 57

Strongest on insiders (57), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$237.61

1 buy, 1 buyer

Sold

$241.43

2 sales

Planned sales

under a 10b5-1 plan